Komori
Daiichi (7643) · RiskMitigated

Impact on results from the spread of COVID-19 and employee infections

First written in FY2020-Q2. 4 of 7 entries say "Restated". Latest entry: FY2023.

7entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2020-Q2 – FY2020-Q3RestatedFY2021-Q2 – FY20212020: 320202021: 320212022: 020222023: 12023
Same theme, other companies
Risk of COVID-19 impacts on business activities, supply chains, demand and financial performanceA theme 1257 companies write about · 1269 as a headwind · 6 as a tailwind

The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1283 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2023MitigatedAnnual report

    「COVID-19 finally began to subside this year, and following the change in its classification under the Infectious Diseases Act to a “Category V infectious disease” in May, the recovery in human mobility, including inbound visitors, and the normalization of economic activity progressed.」

    The description has changed from the previous risks of the spread of infection and disruption to operations and supplies to the subsiding pandemic and the normalization of economic activity following its reclassification as a Category V infectious disease.
  2. FY2021RestatedAnnual report

    「The company is taking measures against COVID-19, giving the safety of customers and employees the highest priority. However, if infections occur at stores, sales headquarters, distribution centers, prepared-food centers or business partners, disrupting store operations or product supplies, store sales could decline and the company's business performance could be affected.」

    The company continues to identify as a business risk the possibility that infections could disrupt store operations and product supplies and reduce sales.
  3. FY2021-Q3RestatedAnnual report

    「Meanwhile, the novel coronavirus infection showed no sign of ending, and economic activity was significantly restricted by the issuance of a state of emergency and requests for people to refrain from going out. Individual behavior and corporate activity stagnated, leaving the economic outlook uncertain.」

    The company continues to describe the potential impact on the business environment from the continuing COVID-19 pandemic and declarations of a state of emergency and requests for people to refrain from going out.
  4. FY2021-Q2RestatedAnnual report

    「Meanwhile, there are still no signs that COVID-19 is subsiding, and the economic outlook remains uncertain amid possible declarations of a state of emergency and requests for people to refrain from going out.」

    The company continues to describe the lack of a clear end to COVID-19 and the ongoing declarations of a state of emergency and requests for people to refrain from going out.
  5. FY2020WorsenedAnnual report

    「The company is taking measures against COVID-19, giving the safety of customers and employees the highest priority. However, if infections occur at stores, sales headquarters, distribution centers, prepared-food centers or business partners, disrupting store operations or product supplies, store sales could decline and the company's business performance could be affected.」

    The scope of the risk has expanded from the previous description of a limited impact from employee infections to the possibility that infections at stores, headquarters, various centers or business partners could disrupt operations and supplies and reduce sales.
  6. FY2020-Q3RestatedAnnual report

    「With respect to the impact of the spread of COVID-19 on the business, if employees or others become infected, the Company's business results could be affected, although the impact would be limited.」

    The company continues to describe the potential impact on business performance from the spread of COVID-19 and infections among employees and others as a limited risk.
  7. FY2020-Q2First statedAnnual report

    「With respect to the impact of the spread of COVID-19 on the business, if employees or others become infected, the Company's business results could be affected, although the impact would be limited.」

    The spread of COVID-19 and the possibility that employee infections could affect business results are identified as a continuing, limited business risk.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Daiichi yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impact on results from the spread of COVID-19 and employee infections | DAIICHI CO.,LTD. (7643) | Komori